E. VICTOR ADLIN, M.D.
This content is PDF only. Please click on the PDF icon to access.
Estrogen use in postmenopausal women began to decline 5 years ago, even before the proliferation of reports indicating an association with endometrial cancer. Does this trend accurately reflect the balance of therapeutic benefits and adverse effects? The value and potential risks of hormone treatment were discussed at a symposium, Estrogen Therapy in Clinical Medicine, at the 61st Annual Meeting of the Endocrine Society, 13 to 15 June 1979, at Anaheim, California.
Proven benefits of estrogen administration after menopause are twofold: relief of symptoms caused by inadequate circulating estrogen, and diminution of the degree of bone loss that occurs commonly in
ADLIN EV. Postmenopausal Estrogen Therapy. Ann Intern Med. ;91:488–489. doi: 10.7326/0003-4819-91-3-488
Download citation file:
Published: Ann Intern Med. 1979;91(3):488-489.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use